Sunlenca

lenacapavir

Approval

ApplicationNDA 215973
Approval dateDec 22, 2022
Approval year2022
SponsorGilead Sciences INC

FDA-approved use

To treat adults with HIV whose HIV infections cannot be successfully treated with other available treatments due to resistance, intolerance, or safety considerations

Approval package

Query with Claude

The fda-analyst skill answers natural-language questions about this approval by fetching the relevant FDA review PDFs at query time.

git clone https://github.com/cbetz/trove
cp -r trove/skills/fda-analyst ~/.claude/skills/

Example prompts for Sunlenca: